Global Cancer Genomic Testing market cagr 12.20%

Page 1


Cancer Genomic Testing Market

Cancer Genomic Testing Market Scope: Industry

Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Cancer

Genomic Testing Market Size and Growth

The Cancer Genomic Testing market is experiencing substantial growth, driven by increased cancer incidence and advancements in genomic technologies. The global market size is projected to reach approximately $18 billion by 2027, reflecting a CAGR of around 10%. Enhanced diagnostic capabilities and personalized medicine continue to propel market conditions favorably. Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Myriad Genetics

◍ Centogene AG

◍ Color Genomics

◍ Quest Diagnostics

◍ 23andMe Inc.

◍ Gene By Gene Ltd.

◍ LabCorp

◍ Positive Bioscience

◍ Bio-Rad Laboratories

◍ Illumina, Inc.

◍ Agilent Technologies

◍ Thermo Fisher Scientific

The cancer genomic testing market features key players like Myriad Genetics, LabCorp, and Illumina. These companies enhance testing accessibility, innovate technologies, and foster partnerships to expand applications. Revenue highlights include Myriad Genetics with $844 million, LabCorp at $3.1 billion, and Illumina reaching $4.5 billion.

Request Sample Report

Market Segmentation

By Application

◍ Hospitals

◍ Clinics

◍ Diagnostic Laboratories

◍ Academic and Research Institutes

◍ Others

By Product

◍ Breast Cancer Genomic Testing

◍ Lung Cancer Genomic Testing

◍ Blood Cancer Genomic Testing

◍ Liver Cancer Genomic Testing

◍ Stomach Cancer Genomic Testing

◍ Others

Request Sample Report

$ 56.53 Billion

Request Sample Report

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.